Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 06.07.2026 1 Am J Med 3 Ann Intern Med 2 Biochem Biophys Res Commun 5 BMC Ophthalmol 2 BMC Pediatr 1 Br J Ophthalmol 8 Diabet Med 2 Diabetes 1 Diabetes Care 17 Diabetes Obes Metab 7 Diabetologia 1 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 1 J Clin Endocrinol Metab 1 J Diabetes Complications 1 J Immunol 1 J Nutr 1 Med Care 1 Metabolism 1 PLoS Comput Biol 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. PAN SY, Weng CH, Sheen YJ, Tsai SF, et al
   GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.
   Am J Med. 2026 Jun 30:S0002-9343(26)00487-0. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. ARTERBURN D, Curtis LH, Toh S, Bradley MC, et al
   Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
   Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-25-05468.
   PubMed         Abstract available
   
   
3. CURTIS LH, Arterburn D, Toh S, Guo J, et al
   Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
   Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00202.
   PubMed         Abstract available
   
   
4. LIU M, Cheng Z, Lu L, Cai H, et al
   Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.
   Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-25-04623.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. TANG D, Yao H, Bao W, Zhai Y, et al
   Integrative analysis of machine learning and single-cell sequencing identifies IGHG1 as a therapeutic target for epimedium in diabetes-gastric cancer comorbidity.
   Biochem Biophys Res Commun. 2026;829:154160.
   PubMed         Abstract available
   
   
6. HUANG Y, Ju S, Li S
   Research progress on the association between diabetes mellitus and risk of cancer: From epidemiology to molecular mechanisms.
   Biochem Biophys Res Commun. 2026;829:154205.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

7. YANG Q, Hassan W, Ahmed H, Zheng H, et al
   Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis.
   BMC Ophthalmol. 2026 Jun 30. doi: 10.1186/s12886-026-05036.
   PubMed         Abstract available
   
   
8. KONTTINEN A, Wirkkala J, Kubin AM, Ohtonen P, et al
   Assessment of real-life visual outcomes and treatment efficacy of diabetic macular edema in patients with type 2 diabetes.
   BMC Ophthalmol. 2026 Jun 30. doi: 10.1186/s12886-026-05083.
   PubMed         Abstract available
   
   
9. BORAL SK, Agarwal D, Chakraborty D, Das A, et al
   Real-world efficacy and safety of Brolucizumab injection in vitrectomised eyes (BIVE) - a prospective multicentric study.
   BMC Ophthalmol. 2026 Jan 24. doi: 10.1186/s12886-026-04621.
   PubMed        
   
   
10. LUO Y, Xia Y, Gong X, Hao M, et al
    GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential.
    BMC Ophthalmol. 2026;26:12.
    PubMed         Abstract available
    
    
11. BULAVA EV, Vorobyova IV, Dmitriev IV, Balkarov AG, et al
    Retinal hemoperfusion and vascular endothelial function after pancreatic transplantation.
    BMC Ophthalmol. 2025;25:461.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

12. FATANI TH
    KCNJ11 (p.Arg192Cys)-associated MODY13 with coexisting autoimmunity in a child, a case report.
    BMC Pediatr. 2026;26:273.
    PubMed         Abstract available
    
    
13. MELIN J, Tamura R, O'Donnell H, Johnson SB, et al
    Child and mother study satisfaction in a longitudinal study of children at-risk for type 1 diabetes.
    BMC Pediatr. 2026 Jul 2. doi: 10.1186/s12887-026-07251.
    PubMed         Abstract available
    
    

    
    Br J Ophthalmol

14. GIL O, Arad A, Fogel M, Vorobichik-Berar O, et al
    Real-world integration of an autonomous artificial intelligence system for diabetic retinopathy screening in an endocrinology outpatient clinic.
    Br J Ophthalmol. 2026 Jun 29:bjo-2025-328991. doi: 10.1136/bjo-2025-328991.
    PubMed         Abstract available
    
    

    
    Diabet Med

15. FLABOURIS K, Pearson OR, Morey K, Edwards SM, et al
    Perioperative glycaemic profiles in Aboriginal and Torres Strait Islander people with diabetes mellitus.
    Diabet Med. 2026 Jun 28:e70400. doi: 10.1111/dme.70400.
    PubMed         Abstract available
    
    
16. YANG D, Fan Y, Xu Y, Jin K, et al
    Prognostic models for diabetic kidney disease outcomes: A systematic review.
    Diabet Med. 2026 Jun 30:e70391. doi: 10.1111/dme.70391.
    PubMed         Abstract available
    
    
17. SANTOVA A, Neuman V, Amaratunga SA, Drnkova L, et al
    Managing type 1 diabetes during sustained physical activity at a diabetes camp: An adaptive prandial bolus reduction algorithm for children using automated insulin delivery.
    Diabet Med. 2026 Jun 30:e70402. doi: 10.1111/dme.70402.
    PubMed         Abstract available
    
    
18. VIDOU A, Pit-Ten Cate IM, Campbell FM, Ware J, et al
    Cambridge hybrid closed-loop use in very young children with type 1 diabetes: Parental expectancies during long-term home use.
    Diabet Med. 2026 Jul 1:e70408. doi: 10.1111/dme.70408.
    PubMed         Abstract available
    
    
19. CUNNINGHAM H, Jenkins A, O'Neal DN, Lee MH, et al
    Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review.
    Diabet Med. 2026 Jul 1:e70372. doi: 10.1111/dme.70372.
    PubMed         Abstract available
    
    
20. RODRIGUES F, White M, O'Connell MA
    Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?
    Diabet Med. 2026 Jul 1:e70382. doi: 10.1111/dme.70382.
    PubMed         Abstract available
    
    
21. MULLEY JF
    Prevalence, duration, and clinical implications of continuous glucose monitor measurement limit capping in type 1 diabetes.
    Diabet Med. 2026 Jul 2:e70412. doi: 10.1111/dme.70412.
    PubMed         Abstract available
    
    
22. ZHENG J, Zhang J
    Refining metabolic-response signals after liraglutide therapy in type 1 diabetes.
    Diabet Med. 2026 Jul 3:e70417. doi: 10.1111/dme.70417.
    PubMed        
    
    

    
    Diabetes

23. TRICO D, Jiang L, Spicer D, Page K, et al
    Ketone Bodies Derived From Medium-Chain Triglycerides Support Brain Metabolism and Function Under Hypoglycemia in Type 1 Diabetes Mellitus.
    Diabetes. 2026 Jul 1:db260293. doi: 10.2337/db26-0293.
    PubMed         Abstract available
    
    
24. ZHANG Y, Yu N, Fang R, Chen S, et al
    Targeting the ADA/ADO Axis Rescues beta-Cell Failure in Type 2 Diabetes.
    Diabetes. 2026 Jun 30:db260052. doi: 10.2337/db26-0052.
    PubMed         Abstract available
    
    

    
    Diabetes Care

25. CHEN LR, Cooksley T, Kochhar R, Titus Raj EJ, et al
    Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.
    Diabetes Care. 2026 Jul 1:dc260700. doi: 10.2337/dc26-0700.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

26. CHEE YJ, Acharyya S, Liew H, Seow CJ, et al
    First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial.
    Diabetes Obes Metab. 2026 Jul 3. doi: 10.1111/dom.71056.
    PubMed         Abstract available
    
    
27. CLAUDEL SE, Verma A
    Trends in Prevalence of Diabetes, Pre-Diabetes, and Cardiometabolic Risk Factor Control Among U.S. Adults, 2013-2023.
    Diabetes Obes Metab. 2026 Jul 3. doi: 10.1111/dom.71059.
    PubMed         Abstract available
    
    
28. NI J, Lu J, Gao F, Li M, et al
    Impact of iGlarLixi on Glycaemic Control Depth and Variability in Asian Pacific People With Type 2 Diabetes: A Post Hoc Analysis of LixiLan-O-AP and LixiLan-L-CN.
    Diabetes Obes Metab. 2026 Jul 1. doi: 10.1111/dom.71036.
    PubMed         Abstract available
    
    
29. STROJEK K, Liebl A, Mumbaikar NN, Sogaard SB, et al
    Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8).
    Diabetes Obes Metab. 2026 Jul 1. doi: 10.1111/dom.71049.
    PubMed         Abstract available
    
    
30. PIEBER TR, Bajaj HS, Fluhr G, Klein KR, et al
    Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once-Weekly Basal Insulin Icodec.
    Diabetes Obes Metab. 2026 Jul 1. doi: 10.1111/dom.71050.
    PubMed         Abstract available
    
    
31. PURCELL AR, Longfield MSG, Rodrigo N, Glastras SJ, et al
    Tirzepatide Is Associated With Improved Metabolic Outcomes in People With Type 1 Diabetes and Overweight or Obesity: A Retrospective Cohort Study.
    Diabetes Obes Metab. 2026 Jul 1. doi: 10.1111/dom.71063.
    PubMed         Abstract available
    
    
32. ZHANG JR, Yeung RO, Manca DP, Singh P, et al
    The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort.
    Diabetes Obes Metab. 2026 Jun 30. doi: 10.1111/dom.71048.
    PubMed        
    
    
33. CAO Y, Zhao J, Liu X, Liu C, et al
    Modelling the Clinical and Complication-Related Economic Burden of Therapeutic Inertia in People With Type 2 Diabetes in China.
    Diabetes Obes Metab. 2026 Jun 30. doi: 10.1111/dom.71011.
    PubMed         Abstract available
    
    
34. MCCARTHY A, Soholm U, Zaremba N, Pouwer F, et al
    Hypoglycaemia Was Not Associated With Depression, Anxiety, Diabetes Distress or Fear of Hypoglycaemia Scores in People With Type 1 or Insulin-Treated Type 2 Diabetes in the Hypo-METRICS Study.
    Diabetes Obes Metab. 2026 Jun 30. doi: 10.1111/dom.71041.
    PubMed        
    
    
35. WU Z, Li Y, Qin Z, Liu Y, et al
    Pubertal Stage-Based One-hour Postload Glucose Thresholds Improve Identification of Prediabetes and Type 2 Diabetes in Children With Overweight or Obesity.
    Diabetes Obes Metab. 2026 Jun 30. doi: 10.1111/dom.70969.
    PubMed         Abstract available
    
    
36. TENTOLOURIS A, Popovic DS, Liarakos AL, Briasoulis A, et al
    GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.
    Diabetes Obes Metab. 2026 Jun 30. doi: 10.1111/dom.71045.
    PubMed         Abstract available
    
    
37. KIM C, Kim S, Lee DY, Han E, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Mental Health Disorders in Type 2 Diabetes: Active Comparator, New User Cohort Study.
    Diabetes Obes Metab. 2026 Jun 30. doi: 10.1111/dom.70985.
    PubMed         Abstract available
    
    
38. HAMBLIN PS, Talic S, Koh HJW, Earnest A, et al
    Shifts in Incident Glucose Lowering Drug Initiation in Type 2 Diabetes From 2014 to 2024: A Population-Based Study.
    Diabetes Obes Metab. 2026 Jun 29. doi: 10.1111/dom.71047.
    PubMed         Abstract available
    
    
39. KUGATHASAN L, Davies MJ, Girard M, Moedt E, et al
    Relationship Between hsCRP, Glycaemic Control and Response to Sotagliflozin in Type 1 Diabetes: A Post Hoc Analysis of the inTandem3 Trial.
    Diabetes Obes Metab. 2026 Jul 3. doi: 10.1111/dom.71039.
    PubMed        
    
    
40. NAKHLEH A, Beeri G, Sudri O, Rotkopf S, et al
    Impact of Autoimmune Hypothyroidism and Celiac Disease on Progression to Diabetes in Individuals Positive for GAD65 or IA-2 Autoantibodies.
    Diabetes Obes Metab. 2026 Jun 29. doi: 10.1111/dom.71044.
    PubMed         Abstract available
    
    
41. LAM D, Freedman BI, Tokita J, Fleming F, et al
    Real-World Associations of KidneyIntelX Risk Stratification With Guideline-Directed Therapy, Kidney Outcomes, and Metabolic Trajectories in Early Diabetic Kidney Disease.
    Diabetes Obes Metab. 2026 Jun 28. doi: 10.1111/dom.70993.
    PubMed         Abstract available
    
    
42. HUSSAIN A, Wahab MU, Qureshi S, Raja UY, et al
    Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan.
    Diabetes Obes Metab. 2026 Jun 28. doi: 10.1111/dom.71043.
    PubMed         Abstract available
    
    

    
    Diabetologia

43. BERGENSTAL RM, Xu Y, Dunn TC, Choudhary P, et al
    Updated glucose management indicator (GMI) better aligns with HbA(1c) than current GMI: implications for clinical practice and reporting.
    Diabetologia. 2026;69:2182-2188.
    PubMed         Abstract available
    
    
44. DU J, Zeng K, Zhang F, Wang Y, et al
    Remodelling of body composition surrounding the diagnosis of type 2 diabetes in three longitudinal cohorts.
    Diabetologia. 2026 Jun 30. doi: 10.1007/s00125-026-06797.
    PubMed         Abstract available
    
    
45. ROTH-SCHULZE AJ, Ngui KM, Martin G, Ashwood P, et al
    Delayed maturation of the milk microbiome in women with type 1 diabetes.
    Diabetologia. 2026 Jun 30. doi: 10.1007/s00125-026-06791.
    PubMed         Abstract available
    
    
46. FARLAND LV, Degnan WJ 3rd, Wang S, Gaskins AJ, et al
    History of infertility, risk of type 2 diabetes and HbA(1c) levels in the Nurses' Health Study II.
    Diabetologia. 2026 Jun 30. doi: 10.1007/s00125-026-06784.
    PubMed         Abstract available
    
    
47. SEBASTIAN-VALLES F, Sager-La Ganga C, Enriquez AJ, Blanco SJ, et al
    Correction: Analysis of glycaemic control with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.
    Diabetologia. 2026 Jul 2. doi: 10.1007/s00125-026-06786.
    PubMed        
    
    
48. RASMUSSEN RS, Nielsen SW, Alstrup L, Larsson TSW, et al
    GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.
    Diabetologia. 2026 Jul 2. doi: 10.1007/s00125-026-06788.
    PubMed         Abstract available
    
    
49. YOON J, Jeon S, Park B
    Baseline and longitudinal joint associations of alcohol consumption and obesity with diabetes risk: evaluating multiplicative and additive interactions.
    Diabetologia. 2026 Jul 2. doi: 10.1007/s00125-026-06790.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

50. QAMBARI H, Hein M, Yu PK, Yu DY, et al
    Degeneration of Interpericyte Tunneling Nanotubes Can Occur in the Absence of Pericyte Loss in Diabetic Retina Disease.
    Invest Ophthalmol Vis Sci. 2026;67:1.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

51. KAUL U, Sinha SK, Singh R, Parida AK, et al
    Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.
    J Am Coll Cardiol. 2026 Jun 24:S0735-1097(26)06637.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

52. SATO F, Mita T, Katakami N, Okada Y, et al
    Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Jun 30:dgag261. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

53. RYDBERG M, Lakhlani D, Sutjiadi BJ, Fox PM, et al
    Diabetes and the risk of entrapment neuropathies of the upper and lower extremity - A propensity score-matched cohort study.
    J Diabetes Complications. 2026;40:109364.
    PubMed         Abstract available
    
    

    
    J Immunol

54. XU Y, Zhong G, Cheng X, Yan J, et al
    ENPP1-dependent USP2 ubiquitination governs SQSTM1-mediated autophagy-dependent ferroptosis in trophoblast cells and exacerbates placental dysfunction in gestational diabetes mellitus.
    J Immunol. 2026;215:vkag127.
    PubMed         Abstract available
    
    

    
    J Nutr

55. CARNAUBA RA, Sarti FM, Marchioni DM, Lotufo PA, et al
    Longitudinal associations of total and class-specific polyphenol intake with incident type 2 diabetes and changes in glycemic markers: Findings from the ELSA-Brasil cohort.
    J Nutr. 2026 Jun 27:101692. doi: 10.1016/j.tjnut.2026.101692.
    PubMed         Abstract available
    
    

    
    Med Care

56. BUCHONGO P, Chen J, Nguyen Q, White-Whilby K, et al
    Association of Neighborhood Socioeconomic Disadvantage and Uptake of Diabetes Prevention Interventions.
    Med Care. 2026 Jun 30. doi: 10.1097/MLR.0000000000002351.
    PubMed         Abstract available
    
    

    
    Metabolism

57. DENG K, Hameete A, Schrauwen P, Wagner R, et al
    Pathophysiology-based subtypes of individuals at high-risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes.
    Metabolism. 2026 Jul 1:156687. doi: 10.1016/j.metabol.2026.156687.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

58. ZHOU Y, Wei K, Liu Y, Li Z, et al
    Variable selection-combined causal mediation analysis for continuous treatments with application to large-dimensional biomedical data.
    PLoS Comput Biol. 2026;22:e1014436.
    PubMed         Abstract available
    
    

    
    PLoS One

59. SHAY AK, Tao W, Patnaik S, Sullivan DK, et al
    Heart failure hospitalization in patients with and without type 2 diabetes: A population-based retrospective cohort study.
    PLoS One. 2026;21:e0351763.
    PubMed         Abstract available
    
    
60. MORI T, Ito H, Kozasa T, Yukawa C, et al
    Association of urinary post-translationally modified fetuin-A fragments with diabetic kidney disease risk stratification in Japanese patients with type 2 diabetes.
    PLoS One. 2026;21:e0353032.
    PubMed         Abstract available
    
    
61. ISMAIL H, Saminathan TA, Abd Hamid HA, Kim Sui W, et al
    Diabetes among Indigenous Orang Asli adults in Peninsular Malaysia: Prevalence and associated factors from Orang Asli Health Survey 2022.
    PLoS One. 2026;21:e0352878.
    PubMed         Abstract available
    
    
62. ALBEKERY MA, Alhomoud IS, Alamer KA, Alanazi AA, et al
    Real-world outcomes of Finerenone in patients with diabetic kidney disease in Saudi Arabia.
    PLoS One. 2026;21:e0352861.
    PubMed         Abstract available
    
    
63. LI X, Muthukumar R, Thepwongsa I
    Stress hyperglycemia ratio predicts mid- to long-term mortality in first-hospitalized type 2 diabetes: Nonlinear threshold and prognostic value.
    PLoS One. 2026;21:e0351307.
    PubMed         Abstract available
    
    
64. ESHETE A, Lambebo A, Getacher L, Kifleyohans T, et al
    Lived experiences of diabetes self-management in North Shoa, Ethiopia: A phenomenological inquiry.
    PLoS One. 2026;21:e0316505.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum